P3 Health Partners Inc reports results for the quarter ended in December - Earnings Summary

• P3 Health Partners Inc PIII reported a quarterly adjusted loss of 22 cents​​ per share for the quarter ended in December, higher than the same quarter last year, when the company reported EPS of $-2.26. The mean expectation of five analysts for the quarter was for a loss of 11 cents per share. Wall Street expected results to range from -19 cents to -5 cents per share.

• Revenue rose 34.3% to $346.86 million from a year ago; analysts expected $302.97 million.

• P3 Health Partners Inc's reported EPS for the quarter was a loss of 22 cents​.

• The company reported a quarterly loss of $25.46 million.

• P3 Health Partners Inc shares had fallen by 27.7% this quarter.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 12% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."

• The average consensus recommendation for the biotechnology & medical research peer group is also "buy"

Wall Street's median 12-month price target for P3 Health Partners Inc is $4.25

This summary was machine generated from LSEG data March 28 at 09:41 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)